STAAR SURGICAL CO — Director's Dealing 2020

May 14, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STAAR SURGICAL CO (STAA)
CIK: 0000718937
Period of Report: 2020-05-11

Reporting Person: Hayashida Jon K. (VP, Global Clinical, Medical)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-05-11	Common Stock	M	21294	$9.30	Acquired	32088	Direct
2020-05-11	Common Stock	M	19178	$7.52	Acquired	51266	Direct
2020-05-11	Common Stock	M	6091	$8.64	Acquired	57357	Direct
2020-05-11	Common Stock	S	46563	$39.11	Disposed	10794	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-05-11	Common Stock Options	$9.30	A	21294	Acquired	2027-03-20	Common Stock (21294)	Direct
2020-05-11	Common Stock Options	$7.52	A	19178	Acquired	2026-03-17	Common Stock (19178)	Direct
2020-05-11	Common Stock Options	$8.64	A	6091	Acquired	2025-07-26	Common Stock (6091)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.89 to $39.10, inclusive.